Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction.
about
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogrammingDiscovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agentsSmall molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agentsDrug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation SpectroscopyDiscovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interactionProbing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.Non-electrophilic modulators of the canonical Keap1/Nrf2 pathwayEngineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage display.Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.Application of fluorescently labeled tracer technique for detection of natural active macromolecules in Chinese medicine.The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction InhibitorsFluorescence polarization assays in high-throughput screening and drug discovery: a reviewDevelopment of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interaction.Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity.Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
P2860
Q27644656-3CAF39C4-D43E-4C03-8CEC-74B214F3F12EQ28085561-88A77A0A-E3A6-4FB3-BB64-43274215B365Q28386244-660EE417-7D61-4D2E-8AF6-C5B5B407100DQ33822548-D5F3797F-4D4D-47D8-8E3E-F2BF1E810051Q34657200-976FB9B1-5670-432D-A34E-11566DAC74C9Q36144939-59B4FF49-B383-4459-93B4-FFD4F002F1ECQ36277241-C59C6F66-F5CC-426F-84E4-68930D337FE5Q36368828-5545DEC4-823F-4DF5-88EB-8AEAF93F1FE1Q36463474-2B42A3B9-EF1E-4510-A779-628CAB9E94A8Q38141004-C7830B0F-B673-42B6-957D-5D4B8CE6A019Q38837451-1523DBE3-B53D-4FDD-8B47-8182DC6188C7Q39953670-790C1134-48F6-4E33-AD53-5EC7E7B50465Q41064004-9F583995-7979-4E9F-9FD5-E2F12938D9E2Q41467248-DC74BA13-6726-4D54-853F-44D1BAB1C8A0Q41897701-4113454C-63FB-4B76-9BEA-05787035568AQ44554497-E095B060-6D0F-4A51-AAA4-AD7C433D7A9DQ57069735-5146658A-68FC-45DB-B825-71BA1412DCCD
P2860
Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@ast
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@en
type
label
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@ast
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@en
prefLabel
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@ast
Optimization of fluorescently ...... ors of Keap1-Nrf2 interaction.
@en
P2093
P2860
P356
P1476
Optimization of fluorescently ...... tors of Keap1-Nrf2 interaction
@en
P2093
Ah-Ng Tony Kong
Daigo Inoyama
Lesa J Beamer
Xinyi Huang
P2860
P304
P356
10.1177/1087057111430124
P50
P577
2011-12-07T00:00:00Z